#drugpricecuts — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #drugpricecuts, aggregated by home.social.
-
Merck & Co. shares slipped after the pharmaceutical giant issued annual guidance below market expectations, citing Trump-era drug price cuts and patent expirations.
#YonhapInfomax #Merck #AnnualGuidance #DrugPriceCuts #EarningsPerShare #PatentExpiration #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=103670 -
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
#YonhapInfomax #ChongKunDang #DrugPriceCuts #DomesticManufacturing #PharmaceuticalIndustry #RDInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102001 -
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
#YonhapInfomax #ChongKunDang #DrugPriceCuts #DomesticManufacturing #PharmaceuticalIndustry #RDInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102001 -
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
#YonhapInfomax #ChongKunDang #DrugPriceCuts #DomesticManufacturing #PharmaceuticalIndustry #RDInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102001 -
Chong Kun Dang CEO Kim Young-joo warned that further drug price cuts could force South Korea's pharmaceutical industry to abandon domestic manufacturing, citing rising costs and declining profitability, while urging policy reforms to protect innovation and R&D investment.
#YonhapInfomax #ChongKunDang #DrugPriceCuts #DomesticManufacturing #PharmaceuticalIndustry #RDInvestment #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=102001 -
Celltrion Chairman Seo Jung-jin sees US drug price cuts as an opportunity, maintains 5 trillion won sales target, and plans to decide on US factory by year-end.
#YonhapInfomax #Celltrion #DrugPriceCuts #Biosimilars #USTariffs #CDMOFactory #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63348